This article is part of the supplement: Basic science, rationale, background and future of denosumab: a RANK ligand inhibitor
Erosive arthritis
-
Correspondence: Georg Schett georg.schett@med3.imed.uni-erlangen.de
Arthritis Research & Therapy 2007, 9(Suppl 1):S2 doi:10.1186/ar2166
Accesses
- Last 30 days: 182 accesses
- Last 365 days: 1697 accesses
- All time: 8970 accesses
Cited by
BioMed Central: 2 citations
|
Benoit Le Goff, Elise Soltner, Céline Charrier, Yves Maugars, Françoise Rédini, Dominique Heymann, Jean-Marie Berthelot Arthritis Research & Therapy 2009, 11:R185 (10 December 2009) |
|
Developments in the scientific understanding of rheumatoid arthritis Jörg J Goronzy, Cornelia M Weyand Arthritis Research & Therapy 2009, 11:249 (14 October 2009) This article is part of a collection on The Scientific Basis of... |